The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ospelnikova T.P.

Mechnikov Research Institute for Vaccines and Sera;
Gamalei National Research Center for Epidemiology and Microbiology

Shitova A.D.

Mechnikov Research Institute for Vaccines and Sera;
Sechenov First Moscow State Medical University

Voskresenskaya O.N.

Sechenov First Moscow State Medical University

Ermilova E.V.

Sechenov First Moscow State Medical University

Neuroinflammation in the pathogenesis of central neuropathic pain

Authors:

Ospelnikova T.P., Shitova A.D., Voskresenskaya O.N., Ermilova E.V.

More about the authors

Read: 3456 times


To cite this article:

Ospelnikova TP, Shitova AD, Voskresenskaya ON, Ermilova EV. Neuroinflammation in the pathogenesis of central neuropathic pain. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(6):7‑13. (In Russ.)
https://doi.org/10.17116/jnevro20221220617

Recommended articles:
Cyto­kine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12
A comprehensive study of Alzheimer’s disease biomarkers in plasma and cere­brospinal fluid. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):43-53
Prospects for treating Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):54-60
The role of mono­cytes in the immu­nopathogenesis of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):23-27
Diffuse changes in the brain in the acute phase of COVID-19 and after infe­ction. Russian Journal of Archive of Pathology. 2025;(1):5-15

References:

  1. Terminology. International Association for the Study of Pain. Accessed August 29, 2021. https://www.iasppain.org/resources/terminology
  2. Watson JC, Sandroni P. Central Neuropathic Pain Syndromes. Mayo Clin Proc. 2016;91(3):372-385.  https://doi.org/10.1016/j.mayocp.2016.01.017
  3. Yahno NN. Bolezni nervnoj sistemy: rukovodstvo dlya vrachej. M.: MEDpress-inform; 2021. (In Russ.).
  4. Solaro C, Trabucco E, Messmer Uccelli M. Pain and multiple sclerosis: pathophysiology and treatment. Curr Neurol Neurosci Rep. 2013;13(1):320.  https://doi.org/10.1007/s11910-012-0320-5
  5. Cook AD, Christensen AD, Tewari D, et al. Immune Cytokines and Their Receptors in Inflammatory Pain. Trends Immunol. 2018;39(3):240-255.  https://doi.org/10.1016/j.it.2017.12.003
  6. Berezhanskaya SB, Luk’yanova EA, Zhavoronkova TE, et al. The modern concept of blood-brain barrier structural-functional organization and basic mechanisms of its resistance disorder. Pediatriya. Zhurnal im. G.N. Speranskogo. 2017;96(1):135-141. Accesses November 28, 2017. (In Russ.). https://pediatriajournal.ru/archive?show=356§ion=4832
  7. Li CX, Liu J, Zhou KX, et al. Involvement of astrocytes activation in orofacial hyperalgesia induced by experimental tooth movement. Orthod Craniofac Res. 2021;24(1):147-154.  https://doi.org/10.1111/ocr.12418
  8. Gonçalves Dos Santos G, Delay L, Yaksh TL, et al. Neuraxial Cytokines in Pain States. Front Immunol. 2020;10:3061. Published 2020 Jan 28.  https://doi.org/10.3389/fimmu.2019.03061
  9. Fan Y, Xue G, Chen Q, et al. CY-09 Inhibits NLRP3 Inflammasome Activation to Relieve Pain via TRPA1. Comput Math Methods Med. 2021;2021:9806690. Published 2021 Aug 14.  https://doi.org/10.1155/2021/9806690
  10. Deng MY, Ahmad KA, Han QQ, et al. Thalidomide alleviates neuropathic pain through microglial IL-10/β-endorphin signaling pathway. Biochem Pharmacol. 2021;192:114727. https://doi.org/10.1016/j.bcp.2021.114727
  11. Inoue K. Role of the P2X4 receptor in neuropathic pain. Curr Opin Pharmacol. 2019;47:33-39.  https://doi.org/10.1016/j.coph.2019.02.001
  12. Tsuda M, Koga K, Chen T, et al. Neuronal and microglial mechanisms for neuropathic pain in the spinal dorsal horn and anterior cingulate cortex. J Neurochem. 2017;141(4):486-498.  https://doi.org/10.1111/jnc.14001
  13. Grace PM, Hutchinson MR, Maier SF, et al. Pathological pain and the neuroimmune interface. Nat Rev Immunol. 2014;14(4):217-231.  https://doi.org/10.1038/nri3621
  14. Hensellek S, Brell P, Schaible HG, et al. The cytokine TNFalpha increases the proportion of DRG neurones expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation. Mol Cell Neurosci. 2007;36(3):381-391.  https://doi.org/10.1016/j.mcn.2007.07.010
  15. Campos ACP, Antunes GF, Matsumoto M, et al. Neuroinflammation, Pain and Depression: An Overview of the Main Findings. Front Psychol. 2020;11:1825. Published 2020 Jul 31.  https://doi.org/10.3389/fpsyg.2020.01825
  16. Rothaug M, Becker-Pauly C, Rose-John S. The role of interleukin-6 signaling in nervous tissue. Biochim Biophys Acta. 2016;1863(6 Pt A):1218-1227. https://doi.org/10.1016/j.bbamcr.2016.03.018
  17. He M, Shi X, Yang M, et al. Mesenchymal stem cells-derived IL-6 activates AMPK/mTOR signaling to inhibit the proliferation of reactive astrocytes induced by hypoxic-ischemic brain damage. Exp Neurol. 2019;311:15-32.  https://doi.org/10.1016/j.expneurol.2018.09.006
  18. Gardoni F, Boraso M, Zianni E, et al. Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1β and NMDA stimulation. J Neuroinflammation. 2011;8(1):14. Published 2011 Feb 11.  https://doi.org/10.1186/1742-2094-8-14
  19. Abramov YuB. Immunncye aspekty central’nyh mekhanizmov boli. 2009;2-8. (In Russ.).
  20. Yabuuchi K, Nishiyori A, Minami M, et al. Biphasic effects of intracerebroventricular interleukin-1 beta on mechanical nociception in the rat. Eur J Pharmacol. 1996;300(1-2):59-65.  https://doi.org/10.1016/0014-2999(95)00862-4
  21. Lazibat I, Rubinić Majdak M, Županić S. Multiple Sclerosis: New Aspects of Immunopathogenesis. Acta Clin Croat. 2018;57(2):352-361.  https://doi.org/10.20471/acc.2018.57.02.17
  22. Hou MM, Li YF, He LL, et al. Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: A meta-analysis. Int Immunopharmacol. 2019;75:105793. https://doi.org/10.1016/j.intimp.2019.105793
  23. Hu X, Huang F, Wang ZJ. CaMKIIα Mediates the Effect of IL-17 To Promote Ongoing Spontaneous and Evoked Pain in Multiple Sclerosis. J Neurosci. 2018;38(1):232-244.  https://doi.org/10.1523/JNEUROSCI.2666-17.2017
  24. Gegelashvili G, Bjerrum OJ. Glutamate transport system as a key constituent of glutamosome: Molecular pathology and pharmacological modulation in chronic pain. Neuropharmacology. 2019;161:107623. https://doi.org/10.1016/j.neuropharm.2019.04.029
  25. Iyengar S, Ossipov MH, Johnson KW. The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine. Pain. 2017;158(4):543-559.  https://doi.org/10.1097/j.pain.0000000000000831
  26. Moseikin I, Levashova A, Myagkova M. Neuromimunnological mechanisms of pain syndrome development. Immunopathol Allergol Infectology. 2017;1:6-15.  https://doi.org/10.14427/JIPAI.2017.1.6
  27. Tsoka P, Barbisan PR, Kataoka K, et al. NLRP3 inflammasome in NMDA-induced retinal excitotoxicity. Exp Eye Res. 2019;181:136-144.  https://doi.org/10.1016/j.exer.2019.01.018
  28. Russell FA, King R, Smillie SJ, et al. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014;94(4):1099-1142. https://doi.org/10.1152/physrev.00034.2013
  29. Kuner R, Kuner T. Cellular Circuits in the Brain and Their Modulation in Acute and Chronic Pain. Physiol Rev. 2021;101(1):213-258.  https://doi.org/10.1152/physrev.00040.2019
  30. Assas BM, Pennock JI, Miyan JA. Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis. Front Neurosci. 2014;8:23. Published 2014 Feb 14.  https://doi.org/10.3389/fnins.2014.00023
  31. An Q, Sun C, Li R, et al. Calcitonin gene-related peptide regulates spinal microglial activation through the histone H3 lysine 27 trimethylation via enhancer of zeste homolog-2 in rats with neuropathic pain. J Neuroinflammation. 2021;18(1):117. Published 2021 May 21.  https://doi.org/10.1186/s12974-021-02168-1
  32. Afroz S, Arakaki R, Iwasa T, et al. CGRP Induces Differential Regulation of Cytokines from Satellite Glial Cells in Trigeminal Ganglia and Orofacial Nociception. Int J Mol Sci. 2019;20(3):711. Published 2019 Feb 7.  https://doi.org/10.3390/ijms20030711
  33. Furgiuele A, Cosentino M, Ferrari M, et al. Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review. J Neuroimmune Pharmacol. 2021;16(2):251-269.  https://doi.org/10.1007/s11481-021-09982-7
  34. Rog DJ, Nurmikko TJ, Friede T, et al. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology. 2005;65(6):812-819.  https://doi.org/10.1212/01.wnl.0000176753.45410.8b
  35. Argenziano M, Tortora C, Bellini G, et al. The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases [published correction appears in Int J Mol Sci. 2020;21(8):]. Int J Mol Sci. 2019;20(23):5875. Published 2019 Nov 23.  https://doi.org/10.3390/ijms20235875
  36. Pellkofer HL, Havla J, Hauer D, et al. The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyperalgesia in patients with neuromyelitis optica. PLoS One. 2013;8(8):e71500. Published 2013 Aug 9.  https://doi.org/10.1371/journal.pone.0071500
  37. Churyukanov MV, Churyukanov VV. Funkcional’naya organizaciya i terapevticheskij potencial endogennoj kannabinoidnoj Sistemy. Eksperimental’naya i Klinicheskaya Farmakologiya. 2004;67:70-78. (In Russ.).
  38. Cabañero D, Ramírez-López A, Drews E, et al. Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain. Elife. 2020;9:e55582. Published 2020 Jul 20.  https://doi.org/10.7554/eLife.55582
  39. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113-e88.  https://doi.org/10.1111/j.1468-1331.2010.02999.x
  40. Vanderwall AG, Milligan ED. Cytokines in Pain: Harnessing Endogenous Anti-Inflammatory Signaling for Improved Pain Management. Front Immunol. 2019;10:3009. Published 2019 Dec 23.  https://doi.org/10.3389/fimmu.2019.03009
  41. Vranken JH, Dijkgraaf MG, Kruis MR, et al. Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain. 2008;136(1-2):150-157.  https://doi.org/10.1016/j.pain.2007.06.033
  42. Kawano T, Eguchi S, Iwata H, et al. Pregabalin can prevent, but not treat, cognitive dysfunction following abdominal surgery in aged rats. Life Sci. 2016;148:211-219.  https://doi.org/10.1016/j.lfs.2016.02.021
  43. Moore RA, Derry S, Aldington D, et al. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. 2015;2015(7):CD008242. Published 2015 Jul 6.  https://doi.org/10.1002/14651858.CD008242.pub3
  44. Huang YN, Tsai RY, Lin SL, et al. Amitriptyline attenuates astrocyte activation and morphine tolerance in rats: role of the PSD-95/NR1/nNOS/PKCγ signaling pathway. Behav Brain Res. 2012;229(2):401-411.  https://doi.org/10.1016/j.bbr.2012.01.044
  45. Cai L, He Q, Lu Y, et al. Comorbidity of Pain and Depression in a Lumbar Disc Herniation Model: Biochemical Alterations and the Effects of Fluoxetine. Front Neurol. 2019;10:1022. Published 2019 Sep 24.  https://doi.org/10.3389/fneur.2019.01022
  46. Rusman T, van der Weijden MAC, Nurmohamed MT, et al. Is Treatment in Patients With Suspected Nonradiographic Axial Spondyloarthritis Effective? Six-Month Results of a Placebo-Controlled Trial. Arthritis Rheumatol. 2021;73(5):806-815.  https://doi.org/10.1002/art.41607
  47. Kwilasz AJ, Green Fulgham SM, Duran-Malle JC, et al. Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related pain. Brain Behav Immun. 2021;93:80-95.  https://doi.org/10.1016/j.bbi.2020.12.016
  48. Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014;33(4):451-459.  https://doi.org/10.1007/s10067-014-2517-2
  49. Metz VE, Jones JD, Manubay J, et al. Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence. Neuropsychopharmacology. 2017;42(9):1825-1832. https://doi.org/10.1038/npp.2017.70
  50. Dai J, Ding Z, Zhang J, et al. Minocycline Relieves Depressive-Like Behaviors in Rats With Bone Cancer Pain by Inhibiting Microglia Activation in Hippocampus. Anesth Analg. 2019;129(6):1733-1741. https://doi.org/10.1038/npp.2017.70
  51. Yang Y, Shi Y, Jia J, et al. Propentofylline reduces mechanical allodynia and induces mitogen-activated protein kinase phosphatase-1: An experimental study in a rat model of acute incisional pain. Neurol Res. 2019;41(10):900-908.  https://doi.org/10.1080/01616412.2019.1642437
  52. Choi GJ, Kang H, Lee JM, et al. Effect of intraperitoneally administered propentofylline in a rat model of postoperative pain. Korean J Pain. 2020;33(4):326-334.  https://doi.org/10.3344/kjp.2020.33.4.326
  53. Fujita M, Tamano R, Yoneda S, et al. Ibudilast produces anti-allodynic effects at the persistent phase of peripheral or central neuropathic pain in rats: Different inhibitory mechanism on spinal microglia from minocycline and propentofylline. Eur J Pharmacol. 2018;833:263-274.  https://doi.org/10.1016/j.ejphar.2018.06.009

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.